NASDAQ · Medical - Care Facilities

AVAH (AVAH) Stock

$9.29 -0.48% NASDAQ: AVAH Healthcare

Valuation

MetricValue
Price$9.29
Market Cap$2.02B
P/E Ratio5.98
P/B Ratio6.53
P/S Ratio0.62
EPS (TTM)$0.00
52-Week High$10.32
52-Week Low$3.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE368.01%
ROA10.17%
ROCE135.90%
Gross Margin32.67%
Operating Margin11.48%
Net Margin10.37%
Debt/Equity6.26
Current Ratio1.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.7B$1.8B$1.9B$2.0B$2.4B
Operating Profit$-36.0M$-642.0M$8.0M$140.0M$265.0M
Net Profit$-117.0M$-662.0M$-135.0M$-11.0M$225.0M
EPS$-0.63$-3.57$-0.71$-0.06$1.05
Op Margin-2.1%-35.9%0.4%6.9%10.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.3B$1.7B$1.6B$1.7B$2.0B
Total Liabilities$1.7B$1.7B$1.7B$1.8B$1.8B
Cash$30.0M$19.0M$44.0M$84.0M$193.0M
Borrowings$1.3B$1.4B$1.5B$1.5B$1.5B

Latest News

Truist Raises Price Target on Aveanna Healthcare Holdings to $11 From $9, Keeps Hold Rating MT Newswires · Jul 14, 2026 Should Value Investors Buy Aveanna Healthcare (AVAH) Stock? Zacks · Jul 13, 2026 Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year? Zacks · Jul 10, 2026 Are You Looking for a Top Momentum Pick? Why Aveanna Healthcare (AVAH) is a Great Choice Zacks · Jul 9, 2026 Despite Fast-paced Momentum, Aveanna (AVAH) Is Still a Bargain Stock Zacks · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-48.0M$23.0M$33.0M$122.0M
Investing Cash Flow$-698.0M$-37.0M$-15.0M$-13.0M$-30.0M
Financing Cash Flow$-53.0M$-2.0M$16.0M$13.0M$6.0M
Net Cash Flow$-107.0M$-11.0M$25.0M$40.0M$109.0M
Free Cash Flow$-27.0M$-60.0M$17.0M$26.0M$115.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.28
EV / EBITDA9.19
FCF Yield8.68%
Quick Ratio1.47
Interest Coverage1.89
Return 1Y134.58%
Return 3Y432.77%
Return 5Y-13.01%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHC $30.95 -3.99% 14.92 $2.88B 0.00%
ADUS $116.46 +2.46% 17.77 $2.17B 0.00%
ARDT $10.73 -1.83% 10.45 $1.54B 0.00%
ASTH $36.33 -0.51% 63.95 $1.80B 0.00%
BKDBrookdale Senior Living Inc. $15.55 +2.61% -17.64 $3.71B 0.00%

About AVAH

AVAH is led by CEO Jeffrey S. Shaner, publicly traded since 2021.

AVAH stock trades at $9.29 with a market capitalization of $2.02B. The stock is valued at a price-to-earnings (P/E) ratio of 5.98, price-to-book of 6.53, price-to-sales of 0.62. Over the past 52 weeks the stock has ranged between $3.73 and $10.32, and currently trades 10.0% below its 52-week high.

On profitability, AVAH generates a return on equity (ROE) of 368.01% — well above the market average, a sign of a high-quality business, return on capital employed of 135.90%, an operating margin of 11.48%, a net profit margin of 10.37%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides